Study of a New Technique for Imaging Pancreatic Cancer

NCT04883775 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Tumors That Express CA19-9

Interventions

DRUG: MVT-2163
DRUG: MVT-5873

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]